blocking agents in some experimental hypertension models such as the spontaneously hypertensive rat, although such models are effective when attempting to manage hypertension in humans (6) . In animals, also, effects of these agents on blood pressure differ depending on the dose, route of administration, and whether or not anesthesia is used.
We investigated the effects of j3-adrenoceptor blocking agents on blood pressure in conscious normotensive rats and in anesthetized rats by changing the routes of administration showed a hypertensive rather than a hypotensive action.
On the other hand, the acute hypotensive effect was seen when optimal doses of these agents were given i.p.. In the present study, therefore, we investigated the effects of i.p. administrations of nine ,3-adrenoceptor blocking agents on blood pressure and heart rate in conscious normotensive rats and compared the hypotensive activities among these agents.
Male Kyoto Wistar strain rats (WKY) weighing 300-350 g were used.
In a conscious but slightly restrained state, the systolic blood pressure (SBP) was measured using an electro sphygmomanometer (Narco Biosystem Co.) at 30 minutes, 1, 2, 3, 4, 5, 6 and 24 hours after a single i.p. administration of a given dose of one of 13-adrenoceptor blocking agents. Rats were warmed for 10--15 minutes at 35-2"C before attempting a measurement. Four pressure measurements were recorded for each rat, and the mean was taken as the SBP.
The heart rate (HR) was measured by counting the excursions of the SBP tracings. The basal SBP of the rats was 125 1 mmHg (110-135 mmHg) and HR was 335 =!-3 beats,'min (300-380 beats/min). Though all of the adrenoceptor blocking agents examined produced a hypotensive effect in WKY, the effective doses, hypotensive activities and du rations varied with each agent. Among these compounds, the most effective was pindolol which produced a marked hypotensive effect in a dose of 0.1 mg/kg (31 19 mmltg) (Fig. 1) .
FIG. 1.
Eriects of pindolol and propranolol on systolic blood pressure (SBP) and heart rate (FIR) in WKY. Number of rats used is indicated in parentheses. Vertical bars represent standard error of the mean. Significant difference from control (saline i.p.): *Xp "0.01. "**p '0.001.
FIG. 2. Effects of ,~-adrenoceptor blocking agents on systolic blood pressure (SBP)
and heart rate (HR) in WKY.
With a low dose of 0.01 rng/kg, however, pindolol increased rather than reduced the SBP (13k3 mmHg). Propranolol, I and 5 nig/kg, also reduced the SBP by 17-!-4 mmHg and 26-1-2 mmHg, respectively (Fig. 1) . With alprenolol, carteolol, bufetolol, timolol, practolol , acebutolol and atenolol the fall of SBP was also observed, but the hypotensive actions of these drugs were less potent than that of pindolol and propranolol and were not dose-dependent (Fig. 2) .
Since doses of f3-adrenoceptor blocking agents used for the block of cardiac p3-receptor are lower than those which produced a fall in SBP, it is difficult to say that the hypotensive actions of E3-adrenoceptor blocking agents were due to the (3-blocking activity. Roba et al. (7) reported that the order of the hypotensive potencies of (3-adrenoceptor blocking agents has no correlation with their 13-adrenoceptor blocking potencies.
The HR was increased with all doses of pindolol, carteolol and practolol and the high dose of alprenolol which possesses an intrinsic sympathomimetic action, and was decreased by bufetolol, timolol, acebutolol, and atenolol (Figs. 1, 2 ). On the other hand, the HR was not affected by propranolol with the most effective dose and was decreased with a dose which had no effect on the SBP. The decrease in HR produced by the low dose of propranolol may be due to blockade of the sympathetic tone to the heart. The apparent absence of the effect of propranolol at the hypotensive dose on the HR may be due to the increased sympathetic tone initiated by hypotension which might overcome the 3-adreno ceptor blocking action of propranolol.
The present findings suggest that the effects of intraperitoneal administration of (3 adrenoceptor blocking agents in WKY are similar to those obtained when these agents are used clinically. The mechanism of antihypertensive activity of 8-adrenoceptor blocking agents is being studied in our laboratory, using these methods.
